Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes.
Dei Cas A, Aldigeri R, Mantovani A, Masulli M, Palmisano L, Cavalot F, Bonomo K, Baroni MG, Cossu E, Cavallo G, Cimini FA, Buzzetti R, Mignogna C, Leonetti F, Bacci S, Trevisan R, Morieri ML, Pollis RM, Targher G, Vigili de Kreutzenberg S. Dei Cas A, et al. Among authors: aldigeri r. J Clin Endocrinol Metab. 2023 Aug 18;108(9):e789-e798. doi: 10.1210/clinem/dgad127. J Clin Endocrinol Metab. 2023. PMID: 36881927
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus.
Mantovani A, Morieri ML, Palmisano L, Masulli M, Cossu E, Baroni MG, Bonomo K, Cimini FA, Cavallo G, Buzzetti R, Mignogna C, Leonetti F, Bacci S, Trevisan R, Pollis RM, Aldigeri R, Cas AD, de Kreutzenberg SV, Targher G. Mantovani A, et al. Among authors: aldigeri r. Cardiovasc Diabetol. 2023 Aug 10;22(1):204. doi: 10.1186/s12933-023-01945-x. Cardiovasc Diabetol. 2023. PMID: 37563618 Free PMC article.
Efficacy of a training programme for the management of diabetes mellitus in the hospital: A randomized study (stage 2 of GOVEPAZ healthcare).
Dei Cas A, Aldigeri R, Ridolfi V, Vazzana A, Ciardullo AV, Manicardi V, Sforza A, Tomasi F, Zavaroni D, Zavaroni I, Bonadonna RC. Dei Cas A, et al. Among authors: aldigeri r. Diabetes Metab Res Rev. 2023 Nov;39(8):e3708. doi: 10.1002/dmrr.3708. Epub 2023 Aug 13. Diabetes Metab Res Rev. 2023. PMID: 37574863 Clinical Trial.
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus.
Csermely A, Mantovani A, Morieri ML, Palmisano L, Masulli M, Cossu E, Baroni MG, Bonomo K, Cimini FA, Cavallo G, Buzzetti R, Mignogna C, Leonetti F, Bacci S, Trevisan R, Pollis RM, Aldigeri R, Cas AD, de Kreutzenberg SV, Targher G. Csermely A, et al. Among authors: aldigeri r. Diabetes Metab. 2023 Nov;49(6):101477. doi: 10.1016/j.diabet.2023.101477. Epub 2023 Sep 12. Diabetes Metab. 2023. PMID: 37708990
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus.
Mantovani A, Morieri ML, Aldigeri R, Palmisano L, Masulli M, Bonomo K, Baroni MG, Cossu E, Cimini FA, Cavallo G, Buzzetti R, Mignogna C, Leonetti F, Bacci S, Trevisan R, Pollis RM, Cas AD, de Kreutzenberg SV, Targher G. Mantovani A, et al. Among authors: aldigeri r. Diabetes Metab. 2024 Jan;50(1):101497. doi: 10.1016/j.diabet.2023.101497. Epub 2023 Nov 20. Diabetes Metab. 2024. PMID: 37992857 Free article.
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk.
Fadini GP, Longato E, Morieri ML, Del Prato S, Avogaro A, Solini A; DARWIN-Renal Study Investigators. Fadini GP, et al. Lancet Reg Health Eur. 2024 Feb 1;38:100847. doi: 10.1016/j.lanepe.2024.100847. eCollection 2024 Mar. Lancet Reg Health Eur. 2024. PMID: 38328413 Free PMC article.
Chronic consumption of a bergamot-based beverage does not affect glucose, lipid and inflammatory biomarkers of cardiometabolic risk in healthy subjects: a randomised controlled intervention study.
Maggiolo G, Aldigeri R, Savini C, Mengani M, Maggi M, Frigeri G, Spigoni V, Cinquegrani G, Fantuzzi F, Di Donna L, Tosi N, Bergamo F, Bresciani L, Rosi A, Mena P, Scazzina F, Del Rio D, Bonadonna RC, Dei Cas A. Maggiolo G, et al. Among authors: aldigeri r. Food Funct. 2024 Jun 4;15(11):5842-5854. doi: 10.1039/d4fo00877d. Food Funct. 2024. PMID: 38767145 Clinical Trial.
Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial.
Dei Cas A, Micheli MM, Aldigeri R, Gardini S, Ferrari-Pellegrini F, Perini M, Messa G, Antonini M, Spigoni V, Cinquegrani G, Vazzana A, Moretti V, Caffarra P, Bonadonna RC. Dei Cas A, et al. Among authors: aldigeri r. J Endocrinol Invest. 2024 Apr 2. doi: 10.1007/s40618-024-02320-7. Online ahead of print. J Endocrinol Invest. 2024. PMID: 38565814
Effectiveness of the flash glucose monitoring system in preventing severe hypoglycemic episodes and in improving glucose metrics and quality of life in subjects with type 1 diabetes at high risk of acute diabetes complications.
Dei Cas A, Aldigeri R, Bellei G, Raffaeli D, Di Bartolo P, Sforza A, Marchesini G, Ciardullo AV, Manicardi V, Bianco M, Monesi M, Vacirca A, Cimicchi MC, Sordillo PA, Altini M, Fantuzzi F, Bonadonna RC; Flash-glucose monitoring Emilia Romagna Regional network. Dei Cas A, et al. Among authors: aldigeri r. Acta Diabetol. 2024 Jun 4. doi: 10.1007/s00592-024-02298-x. Online ahead of print. Acta Diabetol. 2024. PMID: 38833007
58 results